First Time Loading...
A

Aurisco Pharmaceutical Co Ltd
SSE:605116

Watchlist Manager
Aurisco Pharmaceutical Co Ltd
SSE:605116
Watchlist
Price: 24.6 CNY -0.65% Market Closed
Updated: Apr 30, 2024
Section:
 

Relative Value

The Relative Value of one Aurisco Pharmaceutical Co Ltd stock under the Base Case scenario is 29.91 CNY. Compared to the current market price of 24.6 CNY, Aurisco Pharmaceutical Co Ltd is Undervalued by 18%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
29.91 CNY
Undervaluation 18%
Relative Value
Price
A
Worst Case
Base Case
Best Case

Valuation Multiples

8.5
P/S
P/S
Price to Sales
8.5
vs History
64
vs Industry
18
Median 3Y
9.4
Median 5Y
9.4
Industry
2.4
Forward
7.4
More Details
38.4
P/E
P/E
Price to Earnings
38.4
vs History
71
vs Industry
12
Median 3Y
44.6
Median 5Y
42
Industry
22.9
Forward
33.1
More Details
26.9
P/OCF
P/OCF
Price to OCF
26.9
vs History
75
vs Industry
17
Median 3Y
41.8
Median 5Y
32.7
Industry
17.1
More Details
65.2
P/FCFE
P/FCFE
Price to FCFE
65.2
vs History
33
vs Industry
10
Median 3Y
-85.5
Median 5Y
45.5
Industry
23.2
More Details
5.3
P/B
P/B
Price to Book Value
5.3
vs History
51
vs Industry
12
Median 3Y
5.5
Median 5Y
5.3
Industry
2.1
More Details
8.2
EV/S
EV/S
Enterprise Value to Sales
8.2
vs History
62
vs Industry
17
Median 3Y
9.1
Median 5Y
8.7
Industry
2.6
Forward
7.1
More Details
14.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
14.8
vs History
80
vs Industry
13
Median 3Y
18.4
Median 5Y
17.7
Industry
5.1
More Details
36.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
36.8
vs History
55
vs Industry
9
Median 3Y
38.7
Median 5Y
37.7
Industry
13.6
Forward
23
More Details
36.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
36.8
vs History
55
vs Industry
12
Median 3Y
38.7
Median 5Y
37.7
Industry
17
More Details
25.9
EV/OCF
EV/OCF
Enterprise Value to OCF
25.9
vs History
71
vs Industry
18
Median 3Y
39.7
Median 5Y
29.9
Industry
15.8
More Details
119.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
119.5
vs History
26
vs Industry
4
Median 3Y
-79
Median 5Y
41
Industry
17.6
More Details
5.5
EV/IC
EV/IC
Enterprise Value to IC
5.5
vs History
73
vs Industry
16
Median 3Y
6.3
Median 5Y
6.3
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Aurisco Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Aurisco Pharmaceutical Co Ltd
SSE:605116
9.9B CNY 8.5 38.4 36.8 36.8
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
699.9B USD 20.5 133.6 60.3 69.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.9T DKK 17 47.1 34.5 37.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
JP
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
82T JPY 255.8 9 733.7 1 771.8 4 320.3
US
Johnson & Johnson
NYSE:JNJ
353.4B USD 4.3 8.7 11.6 15.3
US
Merck & Co Inc
NYSE:MRK
329.4B USD 5.5 902.5 44.8 87.6
UK
AstraZeneca PLC
LSE:AZN
186.4B GBP 5.1 39.3 140.6 225.6
CH
Novartis AG
SIX:NOVN
181.7B CHF 4.3 13.4 9.8 16.2
CH
Roche Holding AG
SIX:ROG
176.3B CHF 3 15.3 8.7 10.4

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.